Prof. Cheng-Wei Huang

Kaiser Foundation Hospital, Los Angeles, California, USA

Prof. Cheng-Wei Huang

Kaiser Foundation Hospital, Los Angeles, California, USA

Co-authors

Following

Followers

Research Focus & Metrics

Explore full metrics on Scilit

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2018 in Journal of Clinical Neuroscience

Journal Article

Outcome of Gamma Knife radiosurgery for trigeminal neuralgia associated with neurovascular compression

8 March 2022 in JAMA Network Open

Journal Article

Association Between Dexamethasone Treatment After Hospital Discharge for Patients With COVID-19 Infection and Rates of Hospital Readmission and Mortality

Cheng-Wei Huang

Albert S. Yu

Hubert Song

Joon S. Park

Stefanie S. Wu

Ernest Shen

Corticosteroids were the first medication class to demonstrate mortality benefit among patients with COVID-19 and are now a cornerstone of COVID-19 treatment.¹^-3 In the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial, the use of dexamethasone, 6 mg/d, up to 10 days or until discharge resulted in lower mortality.¹ However, with no standardized discharge practices, corticosteroid prescription practices at discharge have varied.

8 May 2021 in Infectious Diseases

Journal Article

Characteristics of patients discharged and readmitted after COVID-19 hospitalisation within a large integrated health system in the United States

Cheng-Wei Huang

Prashant P. Desai

Kenneth K. Wei

In-Lu Amy Liu

Janet S. Lee

Huong Q. Nguyen

Limited studies have explored post-discharge outcomes following Coronavirus Disease 2019 (COVID-19) hospitalisation. We sought to characterise patients discharged following a COVID-19 hospitalisati...